Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Denosumab Injection commencing 1st January 2026

NHS England

This public procurement record has 4 releases in its history.

Award

04 Dec 2025 at 17:53

UK7 - Contract Details Notice
Award

02 Oct 2025 at 08:29

UK6 - Contract Award Notice
Tender

07 Aug 2025 at 16:03

UK4 - Tender Notice
Planning

19 Jun 2025 at 18:26

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The NHS England is executing a public procurement process for the "NHS National Framework for Denosumab Injection" starting on 1st January 2026. The procurement process, currently at the award stage, targets the pharmaceutical industry and is categorised under goods in the CPV classification for pharmaceutical products. The process has involved regional and national awards, covering the North, South, Midlands and East, and London, alongside the whole country of the United Kingdom. The framework initially covers the period from 1st January 2026 to 31st December 2026, with a potential extension of up to 24 months at the authority's discretion. Recent notable dates include the publication of the contract notice on 4th December 2025 and the contract signing on 5th November 2025.

This tender presents significant opportunities, especially for large pharmaceutical enterprises and SMEs capable of providing denosumab injections on a substantial scale. Business growth can be achieved by forming strategic partnerships, enhancing delivery capabilities across various UK regions, and meeting stringent health care standards and requirements set by NHS England. Companies like Accord-UK Ltd, Celltrion Healthcare, and Amgen Ltd are examples of suppliers with the capabilities and scale to fulfil these contracts. The open procurement procedure invites competitive bids, encouraging innovation and the potential for service expansion within the pharmaceutical sector.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Denosumab Injection commencing 1st January 2026

Notice Description

Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months) CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/12/2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.

Lot Information

CM/TNS/25/5725/01 - Regional award for Denosumab Injection

CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months)

Renewal: Option or options to extend (at the discretion of the Authority) up to maximum of 24 months.

CM/TNS/25/5725/02 - National award for Denosumab Injection

CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/12/2026 (12 months)

Renewal: Option or options to extend (at the discretion of the Authority) up to maximum of 24 months.

Planning Information

NHS England is seeking to engage with suppliers that are planning to launch denosumab 60mg and/or 120mg injection. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting on 3rd July 2025. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details including presentation, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05506a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/079939-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£57,000,000 £10M-£100M
Lots Value
£57,000,000 £10M-£100M
Awards Value
£52,753,000 £10M-£100M
Contracts Value
£52,753,000 £10M-£100M

Notice Dates

Publication Date
4 Dec 20258 months ago
Submission Deadline
4 Sep 2025Expired
Future Notice Date
30 Jul 2025Expired
Award Date
30 Sep 202511 months ago
Contract Period
1 Jan 2026 - 31 Dec 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

NHS ENGLAND

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
8
Supplier Names

Accord-UK Ltd

Amgen Ltd

Biosimilar Collaborations Ireland Limited

Celltrion Healthcare United Kingdom Limited

Fresenius Kabi Limited

Gedeon Richter UK Ltd

Teva UK Limited

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...